Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708304 · ClinicalTrials.gov registry record · NA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
A NA study of Dementia and Alzheimers Disease, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 510
- Enrollment target
- 1
- Study location
NCT01708304: Completed NA study of Dementia and Alzheimers Disease, sponsored by University of Washington.
NCT01708304 is a NA study of Dementia and Alzheimers Disease that has completed, run by University of Washington. The registered enrollment target is 510 participants, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708304, a NA study of Dementia and Alzheimers Disease, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
- 1
- Study location
Study Summary
The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.
Primary Outcome
Caregivers will track the number of minutes per week the care recipients engage in exercise recommended by the coach.
Conditions Studied
Interventions
- BEHAVIORAL RDAD
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT01708304 record still lists
NCT01708304 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which RDAD is the first listed.
NCT01708304 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01708304 about?
NCT01708304 is a clinical study titled "Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)". The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy ...
What is the current status of trial NCT01708304?
This trial is currently completed. It is a NA study. The enrollment target is 510 participants. The study started on 2012-11. Estimated completion is 2017-06.
What conditions does trial NCT01708304 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Cognitive Impairment, Memory Impairment.
What interventions are being tested in trial NCT01708304?
The interventions under investigation include: RDAD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01708304?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01708304 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01708304's enrollment target sits among peer trials
510 48th of 199 higher than 152 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia